JPRN-jRCT1091220201已完成Unknown
Study of Infliximab Therapy for Multiple Treatment(included IVIG)-resistant Kawasaki Disease
Investigator-initiated Clinical Research(in-house)0 个研究点目标入组 20 人开始时间: 2014年12月9日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients against Multiple Treatment(included IVIG)-resistant Kawasaki Disease (Under 37.5 degrees C within a 48-hour period)
排除标准
- •Past History of Demyelinating Disease
- •Patients less than 6 months of taking BCG
- •Patients with lung tuberculosis
研究者
相似试验
已完成
不适用
Comparative study of Infliximab monotherapy vs combined therapy with azathiopurine for inducing and maintaining clinical remission in steroid-dependent or -resistant ulcerative colitisulcerative colitisJPRN-UMIN000006141Department of Gastroenterology and Hepatology, Kyoto University Hospital50
已完成
不适用
Efficacy of Infliximab as a second Bio in patients with refractory rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000020799Hokkaido University Hospital, Medicine II30
已完成
不适用
Prospective Pilot study of Infliximab Dose-intensification determined by Capsule Endoscopic Evaluation of Small Intestinal Involvements in Patients with Crohn's Diseases diseaseCrohn's diseaseJPRN-UMIN000012790Saitama Medical center20
终止
3 期
Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)Crohn's DiseaseNCT00796250Merck Sharp & Dohme LLC9
已完成
不适用
Study of Infliximab Therapy for IVIG Treatment-resistant Kawasaki Disease.Kawasaki DiseaseJPRN-jRCT1091220086Investigator-initiated Clinical Research (in-house)20